Petros Grivas

No bio available.

Financial relationships

  • Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Acrivon Therapeutics
    Date added:
    06/15/2024
    Date updated:
    06/15/2024
  • Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    ALX Oncology
    Date added:
    06/15/2024
    Date updated:
    06/15/2024
  • Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Genentech
    Date added:
    06/15/2024
    Date updated:
    06/15/2024

Pages

Return to Optimizing Immuno-Oncology: Innovations in Immune Checkpoint Inhibitor Delivery